GW Henssler & Associates Ltd. cut its holdings in shares of Metlife Inc (NYSE:MET) by 12.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 242,644 shares of the financial services provider’s stock after selling 35,072 shares during the quarter. GW Henssler & Associates Ltd.’s holdings in Metlife were worth $9,963,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of the business. FMR LLC increased its holdings in shares of Metlife by 12.3% in the third quarter. FMR LLC now owns 52,498,328 shares of the financial services provider’s stock worth $2,452,721,000 after purchasing an additional 5,760,379 shares during the last quarter. Clearbridge Investments LLC increased its holdings in shares of Metlife by 5.7% in the third quarter. Clearbridge Investments LLC now owns 11,094,762 shares of the financial services provider’s stock worth $518,347,000 after purchasing an additional 595,175 shares during the last quarter. Diamond Hill Capital Management Inc. increased its holdings in shares of Metlife by 3.4% in the third quarter. Diamond Hill Capital Management Inc. now owns 10,890,882 shares of the financial services provider’s stock worth $508,822,000 after purchasing an additional 363,066 shares during the last quarter. Pzena Investment Management LLC increased its holdings in shares of Metlife by 1.9% in the third quarter. Pzena Investment Management LLC now owns 8,470,138 shares of the financial services provider’s stock worth $395,725,000 after purchasing an additional 155,350 shares during the last quarter. Finally, Prudential Financial Inc. increased its holdings in shares of Metlife by 23.3% in the third quarter. Prudential Financial Inc. now owns 4,581,324 shares of the financial services provider’s stock worth $214,040,000 after purchasing an additional 866,060 shares during the last quarter. 77.16% of the stock is currently owned by institutional investors and hedge funds.
In related news, Director Carlos M. Gutierrez acquired 6,400 shares of Metlife stock in a transaction on Monday, December 17th. The shares were bought at an average cost of $39.04 per share, with a total value of $249,856.00. Following the completion of the purchase, the director now directly owns 4,668 shares of the company’s stock, valued at approximately $182,238.72. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.34% of the company’s stock.
NYSE MET traded down $0.41 during trading hours on Tuesday, hitting $44.90. 28,954 shares of the company were exchanged, compared to its average volume of 5,334,613. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.14 and a quick ratio of 0.14. Metlife Inc has a 52 week low of $37.76 and a 52 week high of $55.21. The stock has a market capitalization of $44.71 billion, a P/E ratio of 9.97, a PEG ratio of 0.61 and a beta of 1.21.
Metlife (NYSE:MET) last issued its quarterly earnings data on Thursday, November 1st. The financial services provider reported $1.38 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.11. Metlife had a return on equity of 9.76% and a net margin of 7.62%. The company had revenue of $16.40 billion for the quarter, compared to analysts’ expectations of $15.88 billion. During the same period in the previous year, the firm posted $1.09 earnings per share. The firm’s revenue for the quarter was down 2.2% on a year-over-year basis. As a group, equities research analysts anticipate that Metlife Inc will post 5.33 earnings per share for the current fiscal year.
Metlife declared that its Board of Directors has initiated a stock buyback plan on Thursday, November 1st that allows the company to buyback $2.00 billion in shares. This buyback authorization allows the financial services provider to reacquire up to 4.6% of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s board of directors believes its shares are undervalued.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 13th. Shareholders of record on Tuesday, February 5th will be paid a dividend of $0.42 per share. The ex-dividend date is Monday, February 4th. This represents a $1.68 annualized dividend and a yield of 3.74%. Metlife’s payout ratio is currently 37.33%.
Metlife Company Profile
MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Further Reading: Outstanding Shares, Buying and Selling Stocks
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).
Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.